Nicholls, Stuart G.Zwarenstein, MerrickHey, Spencer P.Giraudeau, BrunoCampbell, Marion K.Taljaard, Monica2021-05-142021-05-142020-09Nicholls, S G, Zwarenstein, M, Hey, S P, Giraudeau, B, Campbell, M K & Taljaard, M 2020, 'The importance of decision intent within descriptions of pragmatic trials', Journal of Clinical Epidemiology, vol. 125, pp. 30-37. https://doi.org/10.1016/j.jclinepi.2020.04.0300895-4356ORCID: /0000-0001-5386-4097/work/91892213https://hdl.handle.net/2164/16471ACKNOWLEGEMENTS This work is supported by the Canadian Institutes of Health Research through the Project Grant competition (competitive, peer-reviewed), award number PJT-153045. CRediT authorship contribution statement Stuart G. Nicholls: Writing - review & editing. Merrick Zwarenstein: Writing - review & editing. Spencer Phillips Hey: Writing - review & editing. Bruno Giraudeau: Writing - review & editing. Marion K. Campbell: Writing - review & editing. Monica Taljaard: Writing - review & editing.8203681engSDG 3 - Good Health and Well-beingRandomized controlled trialclassificationquantitative assessmentretrospectiveQuantitative assessmentClassificationRetrospectiveSYSTEMATIC REVIEWSVACCINEPREVENTIONPRECISIMMUNOGENICITYINTERVENTIONSTOOLR Medicine (General)EpidemiologySupplementary DataR1Journal article10.1016/j.jclinepi.2020.04.030http://www.scopus.com/inward/record.url?scp=85085349788&partnerID=8YFLogxK125